NCT03692325
- Conditions
- Head and Neck Neoplasms, Leukoplakia, Leukoplakia, Oral, +8 more
- Locations
-
- Dana Farber Cancer Institute Boston, Massachusetts, United States
Clinical trial condition
Explore clinical trials studying Leukoplakia, Oral. Study availability and eligibility vary by location and protocol.
NCT03692325
NCT05730855
NCT03239834
NCT00299195